Low dose antigen and low dose adjuvant of LYB004

BIOLOGICAL2 trials

Sponsors

Guangzhou Patronus Biotech Co., Ltd.

Conditions

Herpes Zoster (HZ)Recombinant Zoster VaccineShinglesVZV

Phase 1

Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older

RecruitingNCT06874842

Guangzhou Patronus Biotech Co., Ltd.Herpes Zoster (HZ)

Start: 2025-03-13End: 2026-10-31Target: 92Updated: 2025-04-01

Phase 2

A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 40 Years and Older

Active, not recruitingNCT07311148

Guangzhou Patronus Biotech Co., Ltd.Herpes Zoster (HZ), Recombinant Zoster Vaccine, Shingles +1

Start: 2025-10-23End: 2026-12-31Target: 840Updated: 2025-12-30